Two factories making semaglutide and tirzepatide for US compounders are now on the FDA import alert list. At one, staff were seen hiding papers and pouring samples down sinks.
Recap by typeshit. Full story at Los Angeles Times.
MedPage Today
A JAMA Network Open analysis of Reddit posts also lists fatigue, insomnia and muscle symptoms. MedPage's roundup adds a CagriSema menopause analysis and Walmart's GLP-1 coverage plan.
A short teaser comparing how well people tolerate the two main GLP-1 ingredients, with the full breakdown behind the link.
Doctors quoted by Men's Journal raise concerns about how much GLP-1 users are paying for add-on supplements each month.
The anti-doping agency says many sellers use research chemical labels to dodge FDA scrutiny while selling peptides and SARMs.
A short clip of Rosie O'Donnell discussing the tirzepatide drug Mounjaro. Few details are given beyond the title.
Sinclair told Joe Rogan GLP-1 drugs could double the risk of sudden vision loss. Dr. Tatem says the figures Sinclair cited do come from real data.
Loading…